SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending with retail traders actively discussing price targets and potential for a short squeeze. Despite recent earnings and raised guidance, some express concern over market conditions and volatility. Optimistic investors point to institutional ownership, AI momentum, and potential government reopening as catalysts for a rebound.

Peanut the Squirrel Markets

Peanut the Squirrel Markets ($PNUT) is surging, driven by community enthusiasm and speculative momentum reminiscent of other meme coins. Community members are actively discussing potential price targets and noting high trading volume, with some drawing comparisons to established meme coins and anticipating further gains. The coin's recent price action and increased visibility are fueling the current buzz.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

ONDS is trending due to the recent acquisition of Sentrycs, a counter-UAS technology company, sparking discussions about its potential impact on revenue and market position. The community is weighing the significance of this move amidst a broader market downturn and government shutdown, with some highlighting the company's cash reserves and strategic positioning in the drone sector. There's also considerable debate around dilution risks and future growth prospects.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending as investors flock to privacy coins, with community members discussing its potential to reach $1,000 and comparing it to Bitcoin's early days. A recent Coindesk article has added fuel to the fire, while some traders are pointing to a pullback. The coin's limited supply and focus on shielded transactions are key talking points.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics ($CAPR) is trending as investors eagerly await upcoming data from its Phase 3 HOPE-3 trial for Duchenne Muscular Dystrophy (DMD), with the community actively debating potential outcomes and FDA pathways. Discussions revolve around the trial's endpoints (PUL and LVEF), the possibility of accelerated approval, and the impact of recent FDA decisions on similar therapies. Some are also highlighting the potential of Capricor's StealthX exosome platform.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk Corp. is trending due to optimism around its potential in the inference market and high-bandwidth flash memory, with community members drawing comparisons to past high-growth tech stories. Despite some bearish sentiment focused on profitability, bullish traders are pointing to future earnings estimates and significant volume spikes as potential catalysts. The stock's parabolic year-to-date performance and analyst upgrades are fueling FOMO, while others caution about overvaluation and potential manipulation.

Shiba Inu (SHIB) is a meme token which began as a fun currency and has now transformed into a decentralized ecosystem. During the initial launch, 50% of the supply was allocated into Vitalik Buterin's ethereum wallet.   As a result of that, Vitalik proceeded to donate 10% of his SHIB holdings to a COVID-19 relief effort in India and the remaining 40% is burnt forever. That donation was worth about $1 billion at that time, which makes it one of the largest donation ever in the world.  What is the Shiba Inu community working on right now? The Shiba Inu team launched a decentralized exchange called Shibaswap with 2 new tokens, LEASH and BONE. LEASH is a scarce supply token that is used to offer incentives on Shibaswap. BONE is the governance token for holders to vote on proposals on Doggy DAO.

Shiba Inu

Shiba Inu is trending amid community discussions about potential rallies and long-term holding strategies, with some mentioning a recent ETF filing including SHIB. Despite mixed sentiment, some traders express optimism, while others remain skeptical about its future performance and potential for new all time highs. Community members highlight both bullish and bearish outlooks, and reference the broader meme coin sector.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as discussions revolve around the potential impact of the ongoing bidding war with Pfizer for Metsera, and speculation about an upcoming announcement from the Trump administration regarding drug pricing. Community sentiment is mixed, with some investors expressing frustration over the stock's recent performance, while others remain optimistic about the company's long-term prospects and potential catalysts like oral Wegovy approval and broader market access.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is trending as the community anticipates upcoming news and potential catalysts, particularly related to its pharmaceutical and battery technology ventures. Discussions revolve around the potential impact of the overfunded pension plan and the possibility of new partnerships or contracts. Some investors are drawing parallels to past meme stock rallies, while others highlight the company's undervalued status.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer's stock is active amid an ongoing bidding war with Novo Nordisk for Metsera, a company focused on obesity drugs, with Pfizer filing lawsuits to challenge Novo's acquisition. The community is discussing the implications of this battle, Pfizer's overall strategy in the weight loss market, and whether the company is overpaying for potential acquisitions. Additionally, the stock's dividend and recent earnings are focal points of conversation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The offering was led by ASPI and American Ventures LLC, an investment firm with ties to Dominari Holdings, which is advised by Eric and Donald Jr.</li><li>QLE intends to use the net proceeds from the offering to build and develop laser enrichment production facilities.</li><li>The company stated that the notes will be unsecured and may be convertible into common equity securities of QLE before maturity, as well as upon the occurrence of certain specified events.&nbsp;</li></ul>&nbsp;Shares of ASP Isotopes surged 16% on Friday after its unit Quantum Leap Energy (QLE) announced a $64.3 million private placement of convertible notes to investors, including U.S. President Donald Trump’s sons, Eric Trump and Donald Trump Jr.The offering was led by <a href="https://stocktwits.com/symbol/ASPI">ASPI</a> and American Ventures LLC, with initial closing expected on or about November 10, the company stated.American Ventures is an investment firm with ties to Dominari Holdings Inc., a boutique bank located in Trump Tower. Eric and Donald Jr. advise and invest in Dominari, according to a Bloomberg report.The deal adds to a growing list of high-profile investments tied to Donald Trump’s family. Trump Jr.’s firm, 1789 Capital, has previously invested in rare earth magnet maker Vulcan Elements and aerospace manufacturer Hadrian.<h2 class="st-heading-2">Deal Details</h2>The company stated that the notes will be unsecured and may be convertible into common equity securities of QLE before maturity, as well as upon the occurrence of certain specified events.These include an initial public offering, direct listing, or future equity financing. In each case, the conversion will occur at a price per share equal to the lower of 80% of the per-share price in the applicable transaction or the per-share value of one share of QLE’s common equity, based on a set valuation cap.Quantum Leap Energy, an advanced materials firm developing isotope production technologies, intends to use the net proceeds from the offering to build and develop laser enrichment production facilities.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits around the ASP Isotopes ticker turned ‘neutral’ from ‘bearish’ a day earlier. It was also among the trending tickers on the platform.<figure class="image"><img style="aspect-ratio:918/94;" src="https://news.stocktwits-cdn.com/ASPI_png_83959381cf.webp" alt="ASPI.png" width="918" height="94"><figcaption>ASPI Stock Sentiment Meter and Message Volumes at 02:00 p.m. ET on November 7, 2025 | Source: Stocktwits</figcaption></figure>One user was bullish about the company’s fundamentals.<stembedurl>https://stocktwits.com/scientificway/message/635401201</stembedurl>Year-to-date, ASPI stock has gained by 87%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the ASP Isotopes logo is seen displayed on a smartphone screen.

Trump Sons Participate In QLE Convertible Note Sale: ASP Isotope Stock Surges 16%

Quantum Leap Energy announced a $64.3 million private placement of convertible notes to investors, including U.S. President Donald Trump’s sons, Eric Trump and Donald Trump Jr.

Equity

ASP Isotopes Jumps After Investment By Trump's Boys

ASP Isotopes Jumps After Investment By Trump's Boys One month ago we discussed why isotope-developer ASP Isotopes (ASPI) is emerging as one of the nascent "nuclear" plays to provide fuel for the AI...

<ul class="summary-bullets"><li>ASP Isotopes announced progress in High-Assay Low Enriched Uranium (HALEU) development in the U.K.</li><li>The U.K.’s Department for Energy Security and Net Zero (DESNZ) has approved QLE’s participation in the early engagement process.</li><li>Rich Deakin appointed Senior Vice President and Managing Director of U.K. Strategic Projects.</li></ul>ASP Isotopes Inc. (ASPI) on Wednesday detailed the progress in its efforts to develop High-Assay Low Enriched Uranium (HALEU) in the United Kingdom.&nbsp;The company’s subsidiary, Quantum Leap Energy (QLE), has started preliminary regulatory discussions with U.K. authorities for new nuclear projects.<h2 class="st-heading-2">Regulatory Milestone For Nuclear Fuel Production</h2>The U.K.’s Department for Energy Security and Net Zero (DESNZ) has approved QLE’s participation in the early engagement process with the Office for Nuclear Regulation (ONR).&nbsp;This approval positions Quantum Leap Energy to become the first commercial HALEU producer in the U.K., a critical step for supplying advanced modular reactor designs that require this specialized fuel.<blockquote>“By producing the HALEU required to fuel the next generation of advanced modular reactors, QLE Ltd will contribute directly to the UK’s clean power, energy security, and economic growth agendas.”-Bill Eden, President, QLE</blockquote><h2 class="st-heading-2">Leadership</h2>As part of its U.K. expansion, QLE appointed Rich Deakin as Senior Vice President and Managing Director of U.K. Strategic Projects.&nbsp;<a href="https://stocktwits.com/symbol/ASPI">ASP Isotopes’ stock</a> traded over 2% on Wednesday, after the morning bell. However, on Stocktwits, retail sentiment around the stock remained in ‘bearish’ territory amid ‘low’ message volume levels.&nbsp;<figure class="image"><img style="aspect-ratio:931/103;" src="https://news.stocktwits-cdn.com/Screenshot_2025_11_05_094716_png_c2fd67858b.webp" alt="ASPI’s Sentiment Meter and Message Volume as of 09:35 a.m. ET on Nov. 5, 2025 | Source: Stocktwits" width="931" height="103"><figcaption>ASPI’s Sentiment Meter and Message Volume as of 09:35 a.m. ET on Nov. 5, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user lauded the development.&nbsp;<stembedurl>https://stocktwits.com/CryptoOwly/message/634990127</stembedurl>In October, the company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/asp-isotopes-stock-surges-13-percent-premarket-after-silicon-28-deal-radiopharmacy-acquisition/ch6S1mKR3km">reached</a>&nbsp;its largest enriched silicon-28 supply deal to date and acquired a U.S.-based radiopharmacy to support the expansion of its South African subsidiary, PET Labs.ASP Isotopes’ stock has gained over 85% in 2025 and over 21% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-unity-stock-rising-today/cL2qlSEREGY">Why Is Unity Stock Rising Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

ASP Isotopes Sets Sights On Becoming UK’s First HALEU Supplier: What Does It Mean?

ASP Isotopes announced progress in High-Assay Low Enriched Uranium (HALEU) development in the U.K.

ASP’s subsidiary, Quantum Leap Energy (QLE), has started preliminary regulatory discussions with U.K. authorities for new nuclear projects.


ASP Isotopes Inc. (ASPI) announced on Wednesday the pricing of its underwritten public offering of more than 17 million shares of common stock, with total gross proceeds amounting to approximately $210.3 million.The advanced materials company, which focuses on isotope production technology for various industries, expects the transaction to close on October 16, pending&nbsp;customary closing conditions.The company stated that underwriters will have a 30-day option to buy extra shares valued at around $31.5 million.&nbsp;<a href="https://stocktwits.com/symbol/ASPI">ASP Isotopes’ stock</a> traded over 8% lower in Wednesday’s premarket and was among the top five equity tickers on Stocktwits. Retail sentiment around the stock remained in ‘extremely bullish’ territory amid ‘extremely high’ message volume levels.&nbsp;ASP Isotopes plans to allocate the net proceeds to strengthen its working capital and support ongoing operational costs.&nbsp;On Monday, the company revealed that it had signed a supply agreement in September with a U.S. customer for isotopically pure silicon-28, with shipments scheduled for the first quarter of 2026.Enriched silicon-28 is a critical element for quantum computing and next-generation chip technologies. By eliminating nuclear spin interference found in natural silicon, silicon-28 enables better qubit performance, which is essential for creating stable and scalable quantum processors.The company uses its proprietary Aerodynamic Separation Process (ASP) technology to produce and commercialize enriched isotopes for healthcare and technology markets. It is also developing Quantum Enrichment technology to support isotope production for the nuclear energy sector.ASP Isotopes’ stock has gained over 210% in 2025 and over 384% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/reddit-stock-rises-premarket-goldman-sachs-sees-ads-data-licensing-boost/ch6nYAxR3Nb">Reddit Stock Rises Premarket: Goldman Sachs Sees Boost From Digital Ads, Data Licensing</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

ASP Isotopes Stock Plummets Pre-Market After Announcing Pricing Of Public Offering

The company expects the transaction to close on October 16, pending routine conditions.

ASP Isotopes (ASPI) stock fell 8.8% in extended trading on Tuesday after the company unveiled a proposed offering of its common stock.The move comes after the stock closed at an all-time high on Tuesday. The company said Cantor Fitzgerald and Lucid Capital Markets are the joint book runners of the offering. It did not, however, disclose how much it was looking to raise.Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/ASPI">ASP Isotopes</a> was in the ‘extremely bullish’ territory at the time of writing.<figure class="image"><img style="aspect-ratio:796/92;" src="https://news.stocktwits-cdn.com/ASPI_oct_14_JPG_19d8ad95b9.webp" alt=" ASPI’s Sentiment Meter and Message Volume as of 10:31 p.m. ET on Oct. 14, 2025 | Source: Stocktwits" width="796" height="92"><figcaption>ASPI’s Sentiment Meter and Message Volume as of 10:31 p.m. ET on Oct. 14, 2025 | Source: Stocktwits</figcaption></figure>The company had about 91.91 million shares outstanding as of Aug. 14, along with a market capitalization of about $1.29 billion. Separately, the company revealed that it has filed for a mixed shelf offering of up to $250 million. Businesses use this method to pre-register equities, keeping them on the "shelf," and then quickly sell them when market conditions are favorable.Many retail traders dismissed dilution concerns by citing examples of other stocks that quickly rebounded after a dip in valuation following a stock offering. “This sector is so hot and huge [in] growth that nothing can stop this train,” one Stocktwits user said.<stembedurl>https://stocktwits.com/BioResearcher/message/632346282</stembedurl>Earlier this week, the company shared a couple of recent business updates which has propelled the stock to record highs. The company revealed that it had signed a supply agreement in September with a U.S. customer for isotopically pure silicon-28, with shipments scheduled for the first quarter of 2026.Enriched silicon-28 is a critical element for quantum computing and next-generation chip technologies. By eliminating nuclear spin interference found in natural silicon, silicon-28 enables better qubit performance, which is essential for creating stable and scalable quantum processors.Separately, it said that in October, ASP Isotopes acquired a Florida-based radiopharmacy, representing its PET Labs unit’s first operational footprint beyond South Africa. ASP Isotopes stock has nearly tripled this year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-sable-offshore-stock-plunge-nearly-27-after-hours-today/ch6nivvR3ZO">Why Did Sable Offshore Stock Plunge Nearly 27% After-Hours Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Did ASP Isotopes Stock Tumble Over 8% After-Hours Today?

Earlier this week, the company shared a couple of recent business updates which has propelled the stock to record highs.

DOE Meets With Nuclear Companies Today To Kick Off Defense Production Act Consortium

DOE Meets With Nuclear Companies Today To Kick Off Defense Production Act Consortium Today is October 14, and as the Office of Nuclear Energy wrote back in August, should mark the first meeting of...

The Next Nuclear Story Stock: ASP Isotopes Shares Surge After Supply Contract For Silicon-28 And U.S. Radiopharmacy Acquisition

The Next Nuclear Story Stock: ASP Isotopes Shares Surge After Supply Contract For Silicon-28 And U.S. Radiopharmacy Acquisition ASP Isotopes, a name we pointed out to our subscribers about one week...

ASP Isotopes Inc. (ASPI) announced on Monday that it has locked in its largest enriched silicon-28 supply deal to date and acquired a U.S.-based radiopharmacy to support the expansion of its South African subsidiary, PET Labs.The company signed a supply agreement in September with a U.S. customer for isotopically pure silicon-28, with shipments scheduled for the first quarter of 2026. In October, ASP Isotopes acquired a Florida-based radiopharmacy, representing PET Labs' first operational footprint beyond South Africa.&nbsp;The acquisition is expected to be accretive to 2026 revenues, earnings before interest, taxes, depreciation, and amortization (EBITDA), and earnings per share (EPS).Following the business updates,&nbsp;<a href="https://stocktwits.com/symbol/ASPI">ASP Isotopes’ stock</a> traded over 17% higher on Monday morning, after the opening bell, and was among the top-five trending equity tickers on Stocktwits. Retail sentiment around the stock remained in ‘bullish’ territory amid ‘high’ message volume levels.&nbsp;Enriched silicon-28 is a critical element for quantum computing and next-generation chip technologies. By eliminating nuclear spin interference found in natural silicon, silicon-28 enables better qubit performance, which is essential for creating stable and scalable quantum processors.&nbsp;“Enriched silicon is emerging as a cornerstone material not only for quantum computing but also for high-precision semiconductor and photonics applications. Our goal is to become the world’s most reliable supplier of enriched silane and other isotopically pure gases — a foundation for the technologies driving the next industrial revolution,” said Chief Commercial Officer, Viktor Petkov.&nbsp;The acquired radiopharmacy facility currently provides SPECT imaging services, but PET Labs aims to introduce PET imaging capabilities by 2027.&nbsp;ASP Isotopes’ stock has gained over 123% in 2025 and over 234% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/klarna-joins-google-open-payments-protocol-ap2/ch6S1P4R3kk">Klarna Joins Google’s Open Payments Protocol AP2</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

ASP Isotopes Stock Surges 17% After Silicon-28 Deal, Radiopharmacy Acquisition

The silicon-28 shipments are scheduled for the first quarter of 2026, and the radiopharmacy deal is expected to be accretive to 2026 revenues, EBITDA, and EPS.

ASP Isotopes Stock Surges 11% After Silicon-28 Deal, Radiopharmacy Acquisition

The silicon-28 shipments are scheduled for the first quarter of 2026, and the radiopharmacy deal is expected to be accretive to 2026 revenues, EBITDA, and EPS.



Shares of ASP Isotopes (ASPI) closed 6.1% higher at $9.36 on Friday.Last week, the company struck a four-year supply agreement with Isotopia Molecular Imaging to deliver enriched Gadolinium-160 (Gd-160), a key ingredient in producing Terbium-161 (Tb-161), a promising isotope for targeted radiotherapeutics.ASP will supply the isotope using its proprietary Quantum Enrichment technology from 2026, and&nbsp;the deal is expected to generate at least $1 million per year.The agreement is designed to help overcome persistent supply shortages of Gd-160, enabling Isotopia to advance its Tb-161-based treatments for cancers like prostate and neuroendocrine tumors.“By supplying Gd-160, we are eliminating a major bottleneck in the development of Tb-161 therapies. Our investment in enrichment technology positions us to support the radiopharmaceutical industry’s growing demand for stable isotopes,” said Paul Mann, CEO of ASP Isotopes.“This partnership accelerates the path to clinical adoption of Tb-161, which could redefine cancer treatment paradigms.”Last month, ASP signed a deal to supply enriched uranium to TerraPower, the nuclear energy company backed by Bill Gates.&nbsp;As part of the agreement, TerraPower will provide ASP with a multiple-advance term loan to help fund a planned uranium enrichment facility at Pelindaba, South Africa.Retail sentiment on Stocktwits remained ‘bullish’ ahead of Monday’s trading session.<figure class="image"><img style="aspect-ratio:969/96;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_09_122253_png_3a77496e48.webp" alt="Screenshot 2025-06-09 122253.png" width="969" height="96"><figcaption>ASPI's Sentiment Meter and Message Volume as of 3:17 a.m ET on June 9, 2025 | Source: Stocktwits&nbsp;</figcaption></figure>One user believes the stock should reach at least $20 before considering selling.<stembedurl>https://stocktwits.com/trent1229/message/617231598</stembedurl><a href="https://stocktwits.com/symbol/ASPI">ASP Isotopes stock</a> has gained over 100% year-to-date.

DocuSign expects the new agreement to expedite the advancement of its IAM platform and deliver more intelligent and efficient solutions to its customers. 

ASP Isotopes Stock Jumps On Isotopia And TerraPower Tie-Ups: Retail Stays Bullish

The Isotopia agreement aims to deliver enriched Gadolinium-160 (Gd-160) to aid targeted radiotherapeutics

ASP Isotopes (ASPI) stock jumped in extended trading on Monday after the company signed an agreement to supply enriched uranium to Bill Gates-backed nuclear energy firm TerraPower.Under the agreement terms, Terrpower would provide ASP with a multiple-advance term loan to partially finance a proposed new uranium enrichment facility at Pelindaba, South Africa.The facility would be capable of producing high-assay low-enriched uranium (HALEU) with an annual output of approximately 15 metric tons.The company also agreed to supply HALEU for the first fuel core for TerraPower’s Natrium Plant in Wyoming. ASP expects to provide 150 metric tons of HALEU from 2028 through the end of 2037.The South Africa facility is expected to begin operations in 2027 upon receipt of all required permits and licenses.Monday’s agreement finalized a term sheet agreement between the two companies, which was struck last year.“Nuclear fuel has one of the most severely compromised supply chains of any material in the world. The world is in urgent need of additional suppliers,” ASP CEO Paul Mann said.HALEU is enriched between 5% and 20% and is the key to many advanced, smaller reactors with more power per unit of volume.There is a broad bipartisan support for nuclear power, which the U.S. lawmakers believe could be the answer to the rapid rise in power demand. However, currently, Russia is the only viable HALEU supplier of scale.The companies said they would explore opportunities to produce HALEU within the U.S.Retail sentiment on Stocktwits was in the ‘extremely bullish’ (81/100) territory, while retail chatter was ‘extremely high.’<figure class="image"><img style="aspect-ratio:878/102;" src="https://news.stocktwits-cdn.com/ASPI_May_20_JPG_2e0ea8a23b.webp" alt="ASPI’s Sentiment Meter and Message Volume as of 02:47 a.m. ET on May 20, 2025 | Source: Stocktwits" width="878" height="102"><figcaption>ASPI’s Sentiment Meter and Message Volume as of 02:47 a.m. ET on May 20, 2025 | Source: Stocktwits</figcaption></figure>“This feels like where we were before Fuzzy Panda. This time, though, even though its prospects and potential are the same as then, the company is in a stronger position,” one retail trader said.<stembedurl>https://stocktwits.com/wilmeriken/message/615185094</stembedurl>The stock declined in November after short seller Fuzzy Panda <a href="https://stocktwits.com/news-articles/markets/equity/aspi-stock-slides-after-fuzzy-panda-short-call/cJIWDFNRWc">accused the company</a> of misleading investors. ASP had denied the allegations.<a href="https://stocktwits.com/symbol/ASPI">ASP Isotopes stock</a> has gained 60% year to date (YTD).Also See: <a href="https://stocktwits.com/news-articles/markets/equity/citi-downgrades-patterson-uti-helmerich-and-payne-on-oil-price-risk/ch0dF7jRb8M">Citi Downgrades Patterson-UTI, Helmerich &amp; Payne On Oil Price Risk — Retail Surprised By ‘Brutal’ Selloff</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

ASP Isotopes Rises On Deal With Bill Gates-Backed TerraPower — Retail Says Company Can Finally Move Beyond Short-Seller Report

Under the agreement terms, Terrpower would provide ASP with a multiple-advance term loan to partially finance a proposed new uranium enrichment in South Africa.

ASP Isotopes Rises On Deal With Bill Gates-Backed TerraPower

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Washington, DC.

ASP Isotopes Inc

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Current Price	$9.14
Prev Close	$7.66
Open	$7.39
Dividend Yield	0.00%
50-Day Moving Average	$9.66
Beta	2.31
Avg. Volume	10.38M
PE Ratio	-6.44

52-Week High	$14.49
52-Week Low	$3.65
Market Capitalization	$840.66M
EPS (Annual)	-$0.6307
Price to Book	29.93
Revenue Per Employee	$30,472.25
Enterprise Value/EBITDA	N/A

ASPI
ASP Isotopes Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ASPI News

ASPIASP Isotopes Inc